Insider Transactions in Q4 2025 at Kala Pharmaceuticals, Inc. (KALA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2025
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
967
-3.24%
|
$0
$0.82 P/Share
|
|
Oct 23
2025
|
Mark T Iwicki |
SELL
Open market or private sale
|
Direct |
154,894
-59.94%
|
$0
$0.81 P/Share
|
|
Oct 22
2025
|
Darius Kharabi CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
20,806
-33.25%
|
$0
$0.83 P/Share
|
|
Oct 22
2025
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
46,748
-56.53%
|
$0
$0.83 P/Share
|
|
Oct 22
2025
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
47,768
-57.07%
|
$0
$0.83 P/Share
|
|
Oct 22
2025
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
32,230
-51.9%
|
$0
$0.83 P/Share
|
|
Oct 01
2025
|
Baker Bros. Advisors LP |
SELL
Open market or private sale
|
Indirect |
513,607
-52.14%
|
$513,607
$1.38 P/Share
|